Plante Moran Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8
| Closed | -$1.2K | – | 794 |
|
|
2025
Q1 | $1.2K | Sell |
8
-31
| -79% | -$4.67K | ﹤0.01% | 714 |
|
|
2024
Q4 | $7.2K | Buy |
39
+31
| +388% | +$5.72K | ﹤0.01% | 635 |
|
|
2024
Q3 | $1.58K | Hold |
8
| – | – | ﹤0.01% | 764 |
|
|
2024
Q2 | $1.65K | Hold |
8
| – | – | ﹤0.01% | 712 |
|
|
2024
Q1 | $2.17K | Hold |
8
| – | – | ﹤0.01% | 763 |
|
|
2023
Q4 | $1.89K | Hold |
8
| – | – | ﹤0.01% | 730 |
|
|
2023
Q3 | $1.57K | Hold |
8
| – | – | ﹤0.01% | 672 |
|
|
2023
Q2 | $1.68K | Hold |
8
| – | – | ﹤0.01% | 696 |
|
|
2023
Q1 | $1.62K | Hold |
8
| – | – | ﹤0.01% | 716 |
|
|
2022
Q4 | $1.74K | Hold |
8
| – | – | ﹤0.01% | 747 |
|
|
2022
Q3 | $2K | Sell |
8
-8
| -50% | -$2K | ﹤0.01% | 777 |
|
|
2022
Q2 | $3K | Buy |
16
+8
| +100% | +$1.5K | ﹤0.01% | 757 |
|
|
2022
Q1 | $2K | Sell |
8
-8
| -50% | -$2K | ﹤0.01% | 737 |
|
|
2021
Q4 | $6K | Hold |
16
| – | – | ﹤0.01% | 778 |
|
|
2021
Q3 | $7K | Hold |
16
| – | – | ﹤0.01% | 737 |
|
|
2021
Q2 | $6K | Buy |
16
+8
| +100% | +$3K | ﹤0.01% | 749 |
|
|
2021
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 902 |
|
|
2020
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 769 |
|